Patil Rutuja, Hindlekar Ajit, Jadhav Ganesh Ranganath, Srinidhi S R, Gaikwad Anjali, Shinde Siddharth
Department of Conservative Dentistry and Endodontics, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India.
Department of Dentistry, AIIMS, Nagpur, Maharashtra, India.
J Conserv Dent Endod. 2025 Aug;28(8):727-733. doi: 10.4103/JCDE.JCDE_294_25. Epub 2025 Aug 1.
The aim of the study was to evaluate the antimicrobial properties of calcium hydroxide (CH)-loaded polylactic-co-glycolic acid (PLGA) nanoparticles (NPs) and CH when used as an intracanal medicament (ICM).
Adhering guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis, the review was registered in the Prospective Registration of Systematic Review-CRD42023454265. Databases from January 2000 to December 2023 were examined for studies evaluating the various properties of CH-loaded PLGA NPs compared to conventional ICM-CH. Using the Cochrane risk of bias (ROB)-2 tool for randomized clinical trials (RCTs) through its domains using Review Manager (RevMan) software version 5.3, quality assessment was evaluated. Standardized mean difference (SMD) was used as a summary statistic measure with a random effect model ( < 0.05).
To fulfill eligibility criteria, six studies were included in qualitative synthesis, from which three were fit for meta-analysis. The quality assessment revealed a moderate to low ROB. The pooled estimate through SMD (0.45 [-1.17-0.27]) and the favored intervention group (CH-loaded PLGA NPs) showed that the reduction in smear layer/biofilm was more significant in the intervention group. Indicating the absence of publication bias, no presence of any heterogeneity was revealed by the funnel plot.
It was observed that CH-loaded PLGA NPs showed improved antibacterial properties, greater dentinal tubule penetration, and a significant microbial load reduction.
本研究旨在评估载有氢氧化钙(CH)的聚乳酸-乙醇酸共聚物(PLGA)纳米颗粒(NPs)以及CH作为根管内药物(ICM)时的抗菌性能。
遵循系统评价和Meta分析的首选报告项目指南,本评价在系统评价前瞻性注册库-CRD42023454265中进行了注册。检索了2000年1月至2023年12月的数据库,以查找评估载有CH的PLGA NPs与传统ICM-CH相比的各种性能的研究。通过使用Review Manager(RevMan)软件5.3版本,利用Cochrane偏倚风险(ROB)-2工具对随机临床试验(RCTs)进行各领域的质量评估。采用随机效应模型(<0.05),将标准化均数差(SMD)用作汇总统计量。
为符合纳入标准,六项研究纳入定性合成分析,其中三项适合进行Meta分析。质量评估显示偏倚风险为中度至低度。通过SMD进行的汇总估计(0.45[-1.17 - 0.27])以及更受青睐的干预组(载有CH的PLGA NPs)表明,干预组在减少玷污层/生物膜方面更为显著。漏斗图显示不存在发表偏倚,也未发现任何异质性。
观察到载有CH的PLGA NPs具有改善的抗菌性能、更大的牙本质小管穿透性以及显著降低的微生物负荷。